Update (June 8): Surgisphere’s online COVID-19 Response Center and the four web tools hosted on it have been taken down from the company’s website.
Anonprofit organization in Africa that promoted a tool to help clinicians determine how to allocate limited medical resources among COVID-19 patients is walking back its recommendations in the wake of a scandal involving the company that collaborated on the project.
Surgisphere Corporation, an Illinois-based company founded in 2008 by vascular surgeon Sapan Desai, has come under fire in recent days for failing to obtain independent validation for datasets used in two high-profile studies in The Lancet and the New England Journal of Medicine. Both papers are now retracted.
The Lancet study, which reported safety concerns about the use of the antimalarial drug hydroxychloroquine in coronavirus patients, led the World Health Organization to suspend part of a clinical trial. Testing resumed last week ...